In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes. The research, published in ...

Disability progression in relapsing MS tends to follow one of four distinct patterns, according to a new study.

Jan. 9, 2025 -- Multiple sclerosis (MS) is a complex condition that affects the brain and spinal cord. How does MS impact the body? What are the symptoms of MS? We spoke with Michael Levy, MD, PhD, to ...

In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes. The research, published in ...

—Evidence from a recent study found that improvement in depression symptoms was associated with a reduction in physical, cognitive, and social fatigue in patients with multiple sclerosis. As ...

Cold weather aggravates fatigue and spasticity for some with MS. Learn why and what you can do to stay more comfortable.

Kesimpta is a medication used to treat relapsing forms of multiple sclerosis (MS) and clinically isolated syndrome (CIS). Kesimpta comes as a solution inside single-dose prefilled injection pens or ...

The U.S. Food and Drug Administration (FDA) has issued a warning regarding the risk of anaphylaxis, a rare but severe allergic reaction associated with glatiramer acetate, a medication used to treat ...

Copaxone and its generic form, Glatopa, may lead to anaphylaxis even in patients who’ve been taking the medication for months without incident. The FDA warns that the injectable MS drugs Copaxone and ...

New findings show a similar number of injective-related reactions (IRRs) were reported between the use of ofatumumab (Kesimpta) and ocrelizumab (Ocrevus) in the treatment of multiple sclerosis, but ...